A model of glucose-6-phosphate dehydrogenase deficiency in the zebrafish

Xiaobai Patrinostro, Michelle L. Carter, Ashley C. Kramer, Troy C. Lund

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common genetic defect and enzymopathy worldwide, affecting approximately 400 million people and causing acute hemolysis in persons exposed to prooxidant compounds such as menthol, naphthalene, antimalarial drugs, and fava beans. Mouse models have not been useful because of a lack of significant response to oxidative challenge. We turned to zebrafish (Danrio rerio) embryos, which develop ex utero and are transparent, allowing visualization of hemolysis. We designed morpholinos to zebrafish g6pd that were effective in reducing gene expression as shown by Western blot and G6PD enzyme activity, resulting in a brisk hemolysis and pericardial edema secondary to anemia. Titration of the g6pd knockdown allowed us to generate embryos that displayed no overt phenotype until exposed to the prooxidant compounds 1-naphthol, menthol, or primaquine, after which they developed hemolysis and pericardial edema within 48-72 hours. We were also able to show that g6pd morphants displayed significant levels of increased oxidative stress compared with controls. We anticipate that this will be a useful model of G6PD deficiency to study hemolysis as well as oxidative stress that occurs after exposure to prooxidants, similar to what occurs in G6PD-deficient persons.

Original languageEnglish (US)
Pages (from-to)697-710.e2
JournalExperimental Hematology
Issue number8
StatePublished - Aug 2013

Bibliographical note

Funding Information:
This work was supported by the Children’s Cancer Research Fund . M.L.C. was supported by National Institutes of Health grant T32 CA099967 .


Dive into the research topics of 'A model of glucose-6-phosphate dehydrogenase deficiency in the zebrafish'. Together they form a unique fingerprint.

Cite this